thimerosal has been researched along with Pervasive Child Development Disorders in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (58.33) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Geier, DA; Geier, MR; Haley, BE; Kern, JK; King, PG; Sykes, LK | 1 |
Eslick, GD; Swerdfeger, AL; Taylor, LE | 1 |
Geier, DA; Geier, MR; Hooker, BS; Kern, JK; King, PG; Sykes, LK | 1 |
Geier, DA; Geier, MR; Kern, JK; King, PG; Sykes, LK | 1 |
Fombonne, E; Meilleur, AA | 1 |
Bearss, K; Scahill, L | 1 |
Barrett, C; Bazzano, A; Lehrer, D; Schuster, E; Zeldin, A | 1 |
Parker, SK; Pickering, LK; Schwartz, B; Todd, J | 1 |
Geier, DA; Geier, MR | 1 |
Bennett, A; Fombonne, E; McLean-Heywood, D; Meng, L; Zakarian, R | 1 |
Coleman, L; Geier, DA; Geier, MR; Gladfelter, B; Mumper, E | 1 |
Geier, DA; Geier, MR; Young, HA | 1 |
4 review(s) available for thimerosal and Pervasive Child Development Disorders
Article | Year |
---|---|
Thimerosal exposure and the role of sulfation chemistry and thiol availability in autism.
Topics: Animals; Child; Child Development Disorders, Pervasive; Glutathione; Humans; Mercury; Oxidation-Reduction; Preservatives, Pharmaceutical; Risk Factors; Sulfhydryl Compounds; Thimerosal; Vaccination; Vaccines | 2013 |
Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies.
Topics: Autistic Disorder; Child Development Disorders, Pervasive; Humans; Measles-Mumps-Rubella Vaccine; Mercury; Preservatives, Pharmaceutical; Publication Bias; Thimerosal; Vaccination | 2014 |
The rise in autism and the mercury myth.
Topics: Asperger Syndrome; Autistic Disorder; Bias; Child; Child Development Disorders, Pervasive; Epidemiologic Studies; Humans; Mass Media; Measles-Mumps-Rubella Vaccine; Preservatives, Pharmaceutical; Prevalence; Public Opinion; Thimerosal | 2009 |
Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
Topics: Autistic Disorder; Child; Child Development Disorders, Pervasive; Developmental Disabilities; Diphtheria-Tetanus Vaccine; Diphtheria-Tetanus-Pertussis Vaccine; Ethylmercury Compounds; Half-Life; Humans; Methylmercury Compounds; Preservatives, Pharmaceutical; Research Design; Thimerosal | 2004 |
1 trial(s) available for thimerosal and Pervasive Child Development Disorders
Article | Year |
---|---|
A case-control study evaluating the relationship between thimerosal-containing haemophilus influenzae type b vaccine administration and the risk for a pervasive developmental disorder diagnosis in the United States.
Topics: Age of Onset; Case-Control Studies; Child Development Disorders, Pervasive; Child, Preschool; Female; Haemophilus influenzae type b; Haemophilus Vaccines; Humans; Male; Preservatives, Pharmaceutical; Seizures, Febrile; Thimerosal; Time Factors; United States | 2015 |
7 other study(ies) available for thimerosal and Pervasive Child Development Disorders
Article | Year |
---|---|
A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disorders.
Topics: Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Child; Child Development Disorders, Pervasive; Child, Preschool; Developmental Disabilities; Dose-Response Relationship, Drug; Female; Hepatitis B Vaccines; Humans; Infant; Male; Preservatives, Pharmaceutical; Thimerosal; Tic Disorders; United States | 2014 |
Regression of language and non-language skills in pervasive developmental disorders.
Topics: Adolescent; Adult; Age of Onset; Birth Order; Canada; Child; Child Development Disorders, Pervasive; Child, Preschool; Comorbidity; Developmental Disabilities; Female; Humans; Infant; Language Disorders; Male; Preservatives, Pharmaceutical; Severity of Illness Index; Sex Distribution; Thimerosal; Vaccination; Young Adult | 2009 |
Vaccine-related beliefs and practices of parents of children with autism spectrum disorders.
Topics: Adolescent; Asperger Syndrome; Child; Child Development Disorders, Pervasive; Child, Preschool; Cross-Sectional Studies; Culture; Data Collection; Educational Status; Female; Health Knowledge, Attitudes, Practice; Humans; Infant; Interviews as Topic; Male; Parents; Preservatives, Pharmaceutical; Public Opinion; Socioeconomic Factors; Thimerosal; Treatment Refusal; Vaccination; Vaccines | 2012 |
An assessment of downward trends in neurodevelopmental disorders in the United States following removal of Thimerosal from childhood vaccines.
Topics: Child Development Disorders, Pervasive; Child, Preschool; Female; Humans; Male; Preservatives, Pharmaceutical; Thimerosal; United States; Vaccines | 2006 |
Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
Topics: Adolescent; Age Distribution; Asperger Syndrome; Autistic Disorder; Child; Child Development Disorders, Pervasive; Child, Preschool; Ethylmercuric Chloride; Female; Humans; Immunization; Immunization Schedule; Logistic Models; Male; Measles-Mumps-Rubella Vaccine; Prevalence; Quebec; Sex Distribution; Thimerosal | 2006 |
Neurodevelopmental disorders, maternal Rh-negativity, and Rho(D) immune globulins: a multi-center assessment.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Child; Child Development Disorders, Pervasive; Child, Preschool; Developmental Disabilities; Female; Humans; Male; Mothers; Pregnancy; Prenatal Exposure Delayed Effects; Preservatives, Pharmaceutical; Retrospective Studies; Rh-Hr Blood-Group System; Rho(D) Immune Globulin; Risk Factors; Thimerosal | 2008 |
Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.
Topics: Adolescent; Child; Child Development Disorders, Pervasive; Child, Preschool; Cohort Studies; Developmental Disabilities; Evaluation Studies as Topic; Female; Humans; Infant; Male; Medical Records Systems, Computerized; Preservatives, Pharmaceutical; Proportional Hazards Models; Retrospective Studies; Thimerosal; Vaccines | 2008 |